[Deepen the application of industry-university-research and promote the transformation of results] Professor Liu Baolin from the University of Shanghai for Science and Technology visited and exchanged ideas
Release time:
2023-07-21
The deep integration of industry, academia and research is the core content and important implementation form of innovation-driven development, and is also the strategic focus of national scientific and technological innovation. In order to actively respond to the national strategy, further accelerate the in-depth integration of industry, academia and research, promote school-enterprise cooperation in a wider scope, deeper degree and higher level, and achieve complementary advantages and collaborative innovation, over the years, Yinfeng Hypothermia Medicine Research Center has cooperated with domestic and foreign Scientific research institutes in multiple disciplines cooperate to actively promote the scientific research progress and implementation of cryogenic medicine.
On July 16, Professor Liu Baolin, Dean of the Institute of Science and Technology Development of the University of Shanghai for Science and Technology and Deputy Chairman of the Yinfeng Cryomedicine Expert Committee, visited the Yinfeng Cryomedicine Research Center for a visit and exchange.
Professor Liu Baolin
Dean of the Institute of Science and Technology Development, University of Shanghai for Science and Technology
Ministry of Education Excellent New Century Talents Plan
Leader of the Cryobiology Group of the Biobank Branch of the China Medical Biotechnology Association
Director of Shanghai Collaborative Innovation Center for Tumor Energy Therapy Technology and Devices
Director of Shanghai Biological Resources Cryopreservation Professional Technical Service Platform
Deputy Chairman of Yinfeng Hypothermia Medicine Expert Committee
During the visit, Professor Liu introduced the development history and current situation of cryogenic medicine with great interest. Together with the Yinfeng cryogenic team, they reviewed the specific progress of the Yinfeng life extension plan and its tissue and organ cryopreservation and recovery research projects. Feng’s cryogenic medicine team affirms the results achieved. At the same time, both parties jointly imagined the future vision and bright future of cryogenic medicine.
Professor Liu Baolin and his team are committed to studying cryopreservation methods of human cells and tissues, as well as the mechanism of low-temperature damage to cells and tissues, as well as the cryopreservation and freeze-drying of biological materials. In 2019, Professor Liu Baolin and the Yinfeng cryogenic medicine research team jointly carried out research on "tissue and organ preservation research and system construction of life resource library". As a biomedical resource in urgent need of Jinan City, this project was included in the "Quancheng Scholars" construction project Project, Professor Liu Baolin won the honorary title of "Quancheng Scholar".
Over the years, Yinfeng Cryogenic Medicine has conducted in-depth cooperation with the University of Shanghai for Science and Technology on cryogenic medicine industry, academia and research. Based on the friendly principle of resource sharing, both parties have carried out scientific research cooperation and established a scientific research and production consortium. Conduct in-depth exchanges on cryopreservation and recovery of tissues and organs, and conduct in-depth cooperation on the development of key cryopreservation technologies and equipment. At the same time, the two parties have joined forces in terms of talent training, built a talent internship base, jointly established an education fund, promoted talent exchange and introduction, and achieved gratifying results.
Consolidate scientific research cooperation and promote the transformation of results. Based on the long-term good cooperation foundation and existing achievements between the two parties, in the future, the two parties will continue to work on joint technical research on deep cryopreservation of complex tissues and organs, deepen the cooperation between industry, academia and research in cryogenic medicine, promote the practical implementation of more scientific research results, and create a new platform for cryogenic medicine research and transformation. New Highlands.
“School of Medical Devices and Food” is now renamed as “School of Health Sciences and Engineering”
Here, we also look forward to more leading international and domestic laboratory research teams and scientific research institutes strengthening technical cooperation and translational research to jointly contribute to the development of cryogenic medicine in China.
Attachment: University of Shanghai for Science and Technology
The University of Shanghai for Science and Technology owns the Ministry of Education’s “Minimally Invasive Medical Devices” Engineering Research Center, the Shanghai Key Discipline of “Medical Device Engineering”, and the “Cryogenic Biology Laboratory”. The School of Health Sciences and Engineering under its jurisdiction has long been engaged in research in the field of cryogenic biomedical technology. Including the cryopreservation, freeze-drying and thermal science issues of biological materials (cells, tissues and food materials), some innovative results have been made in the cryopreservation and freeze-drying of important human cells. In recent years, the college has undertaken more than 100 nationally important scientific research projects of various types, with approved funding of more than 100 million yuan; it has won more than ten science and technology awards at the provincial and ministerial levels; it has published more than 600 papers included in SCI and authorized nearly 200 invention patents; completed More than 200 horizontal scientific research results have been transformed, and related research leads the country in the low temperature industry.
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
